S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%
Next Bullish Trade
Sign in
BAYRY

Bayer Aktiengesellschaft OQX · BAYRY

$13.80 +0.20 (+1.47%)
Extended · +1.34σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BAYRY

Momentum reads · latest daily bar
Last
$13.80
+0.20 (+1.47%)
Mkt cap
$54.2B
Healthcare
RSI(14)
61.7
neutral
Stochastic %K
41.6
neutral
MFI(14)
40.1
neutral
ADX(14)
31.5
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $13.4B $2.8B $3.5B $-2.2B 20.6% 26.3%
2025-12-31 $11.4B $-3.8B $4.3B $3.4B -32.8% 38.0%
2025-09-30 $9.7B $-1.0B $-0.5B $0.8B -10.0% -5.6%
2025-06-30 $10.7B $-0.2B $0.0B $0.6B -1.9% 0.1%
2025-03-31 $13.7B $1.3B $2.3B $-1.4B 9.5% 16.9%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BAYRY vs peers

Line BAYRY up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BAYRY MSFT× GOOG× AMZN×
Verdict
Weighted score 0-100 across 4 tickers · best in green
#2
BAYRY
score 54.8
5/5 inputs
Perfect 100 momentum score from 33% one-month surge dominates despite zero sentiment and poor 15 quality rating.
value 80growth 50quality 15momentum 100sentiment 0
#3
MSFT
score 51.9
5/5 inputs
Deep 29% drawdown from 52-week high crushes momentum to just 4, offsetting strong 84 quality score.
value 51growth 43quality 84momentum 4sentiment 100
#1
GOOG
score 58.9
5/5 inputs
Exceptional 83 growth score driven by 82% EPS growth elevates it despite weak 25 value rating.
value 25growth 83quality 87momentum 46sentiment 65
#4
AMZN
score 48.2
5/5 inputs
Weak 33 quality score from low 13% operating margin drags performance despite solid 68 growth rating.
value 36growth 68quality 33momentum 49sentiment 51
BAYRY
Bayer Aktiengesellschaft
$13.80
+1.47%
Snapshot
Price 13.8
Day % 1.47
1M % 32.95
3M % 16.95
YTD % 24.44
Market cap 54229807104.0
ADV ($) 19244983.465991974
Beta 0.83
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 4.01
Dist ATR (σ) 1.34
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm)
P/E (fwd) 11.139633
P/S 1.1986607
EV/EBITDA 8.523
P/B 1.6485983
FCF yield 0.1349
PEG 4.61
Growth
Revenue yoy -0.024
EPS yoy 1.129
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.59918
Operating margin 0.26319
Net margin -0.04765
ROE -0.06928
ROA 0.03637
Debt / Equity 1.34
Interest cov. -0.38
Technicals
RSI(14) 61.7
MACD signal neutral
vs 50-DMA 17.38
vs 200-DMA 26.78
vs 52w high -9.39
HV-30 59.0
Sentiment
Analyst rec 2.25
Target upside 10.33
Insider buy-sell 90d
Risk
Short interest
Days to cover 0.0
Next earnings 2026-08-04
Full BAYRY dashboard →
MSFT
Microsoft Corporation
$393.82
-1.82%
Snapshot
Price 393.82
Day % -1.82
1M % -0.0
3M % -6.29
YTD % -16.73
Market cap 2925466222592.0
ADV ($) 15501831798.361267
Beta 1.13
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.16
Dist ATR (σ) 0.37
OdysseyHQ grade
Confluence 0
Valuation
P/E (ttm) 23.427723
P/E (fwd) 20.324642
P/S 9.191689
EV/EBITDA 16.116
P/B 7.0606165
FCF yield 0.0127
PEG 1.19
Growth
Revenue yoy 0.183
EPS yoy 0.234
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.68309
Operating margin 0.46326
Net margin 0.39341998
ROE 0.34013999
ROA 0.14814
Debt / Equity 0.3
Interest cov. 52.84
Technicals
RSI(14) 51.9
MACD signal neutral
vs 50-DMA -1.92
vs 200-DMA -10.36
vs 52w high -29.1
HV-30 34.3
Sentiment
Analyst rec 1.32143
Target upside 41.86
Insider buy-sell 90d 20
Risk
Short interest 1.2
Days to cover 1.84
Next earnings 2026-07-29
Full MSFT dashboard →
GOOG
Alphabet Inc.
$346.12
-2.17%
Snapshot
Price 346.12
Day % -2.17
1M % -6.73
3M % 4.01
YTD % 9.77
Market cap 4223554551808.0
ADV ($) 7507971248.00293
Beta 1.247
OdysseyHQ zone
Current zone Pullback
Dist 21-EMA % -3.01
Dist ATR (σ) -0.94
OdysseyHQ grade C
Confluence 3
Valuation
P/E (ttm) 26.956385
P/E (fwd) 23.646824
P/S 9.996626
EV/EBITDA 25.804
P/B 8.759427
FCF yield 0.0066
PEG 1.41
Growth
Revenue yoy 0.218
EPS yoy 0.82
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.60368
Operating margin 0.36121
Net margin 0.37919
ROE 0.38884997
ROA 0.14641
Debt / Equity 0.2
Interest cov. 216.8
Technicals
RSI(14) 43.3
MACD signal neutral
vs 50-DMA -5.94
vs 200-DMA 7.84
vs 52w high -14.43
HV-30 36.1
Sentiment
Analyst rec 1.43077
Target upside 23.59
Insider buy-sell 90d
Risk
Short interest
Days to cover 2.13
Next earnings 2026-07-22
Full GOOG dashboard →
AMZN
Amazon.com, Inc.
$247.23
-1.06%
Snapshot
Price 247.23
Day % -1.06
1M % 0.5
3M % -0.99
YTD % 9.15
Market cap 2659480240128.0
ADV ($) 12189345134.532013
Beta 1.461
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 0.6
Dist ATR (σ) 0.19
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm) 29.858696
P/E (fwd) 24.94745
P/S 3.5804608
EV/EBITDA 17.656
P/B 6.016353
FCF yield 0.0037
PEG 1.43
Growth
Revenue yoy 0.166
EPS yoy 0.748
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.50604
Operating margin 0.1314
Net margin 0.12224
ROE 0.24285
ROA 0.06845
Debt / Equity 0.53
Interest cov. 43.79
Technicals
RSI(14) 51.3
MACD signal bull
vs 50-DMA -1.94
vs 200-DMA 5.63
vs 52w high -11.25
HV-30 32.8
Sentiment
Analyst rec 1.32308
Target upside 27.15
Insider buy-sell 90d -24
Risk
Short interest 1.0199999
Days to cover 1.6
Next earnings 2026-07-30
Full AMZN dashboard →

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BAYRY $54B 11.1 1.2 8.5 1.6 59.9% -2.4% 112.9% 13.49%
LLY $1,051B 41.5 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 31.8 19.2 0.9 20.2 4.0 18.8% 2.0% 0.7% 4.57%
JNJ $609B 29.0 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.8 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 0.17%

HolderShares% out
Kahn Brothers Group Inc. 6,513,893 0.17%
Westside Investment Management, Inc. 2,878
PNC Financial Services Group, Inc. 3,030
Atlas Capital Advisors Inc 35,510
Great Lakes Advisors LLC 119,517
Rhumbline Advisers 68,123
Salomon & Ludwin, LLC 2,141
Gamma Investing LLC 41,204
Chicago Trust Co Na 20,097
Sterling Capital Management, LLC 846

Insider activity · 90d

No insider trades for BAYRY in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$14.5
Mean
$15.225
High
$15.8
Analysts
4
Recommendation distribution · period 2026-07-01
6
15
7
Revision trend (2026-04-01 → 2026-07-01): net 19 → 21 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

No CIK found for BAYRY.

About BAYRY

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmaci…

Options picks · BAYRY

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BAYRY

STOCK Act disclosures

Loading…

SEC filings & insiders · BAYRY

EDGAR · live

Loading…

Holders · BAYRY

Institutions & insider activity

Loading…